Literature DB >> 2547839

Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

S S Ahmad1, R Rawala-Sheikh, B Ashby, P N Walsh.   

Abstract

We have studied factor IXa binding and factor X activation with normal platelets and with platelets obtained from a patient with a bleeding disorder and an isolated deficiency of platelet procoagulant activity termed Scott syndrome. In the absence of factor VIIIa and factor X, normal, thrombin-treated platelets exposed 560 +/- 35 sites for factor IXa with a Kd of 2.75 +/- 0.27 mM, compared with 461 +/- 60 sites per patient platelet with Kd of 3.2 +/- 0.33 nM. The addition of factor VIIIa and factor X resulted in a decrease in the Kd for normal platelets to 0.68 nM but had no effect on the Kd for patient platelets. The concentrations of factor IXa required for half-maximal rates of factor X activation for normal (0.52 nM) and patient platelets (2.5 nM) were similar to those determined from equilibrium binding studies. Kinetic parameters for factor X activation by factor IXa showed that the Km and Kcat were identical for normal and patient platelets in the absence of factor VIIIa. In the presence of factor VIIIa, and kcat for patient platelets (163 min-1) was only 33% of that for normal platelets (491 min-1): This result can be explained by the difference in affinity for factor IXa between normal and patient platelets in the presence of factor VIIIa, suggesting impaired factor VIIIa binding to Scott syndrome platelets.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547839      PMCID: PMC329725          DOI: 10.1172/JCI114242

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Interaction of coagulation factor V and factor Va with platelets.

Authors:  P B Tracy; J M Peterson; M E Nesheim; F C McDuffie; K G Mann
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

2.  Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187.

Authors:  J van Rijn; J Rosing; G van Dieijen
Journal:  Eur J Biochem       Date:  1983-06-01

3.  Role of human factor VIII in factor X activation.

Authors:  M B Hultin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

4.  Different requirements for intrinsic factor-Xa forming activity and platelet factor 3 activity and their relationship to platelet aggregation and secretion.

Authors:  P N Walsh; E Camp; D Dende
Journal:  Br J Haematol       Date:  1978-10       Impact factor: 6.998

5.  Factor Va-dependent binding of factor Xa to human platelets.

Authors:  W H Kane; M J Lindhout; C M Jackson; P W Majerus
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

6.  A rapid method for removal of [125I]iodide following iodination of protein solutions.

Authors:  G P Tuszynski; L Knight; J R Piperno; P N Walsh
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

7.  Isolated deficiency of platelet procoagulant activity.

Authors:  H J Weiss; W J Vicic; B A Lages; J Rogers
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

8.  Coordinate binding of factor Va and factor Xa to the unstimulated platelet.

Authors:  P B Tracy; M E Nesheim; K G Mann
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

9.  Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder.

Authors:  J P Miletich; W H Kane; S L Hofmann; N Stanford; P W Majerus
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

10.  Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.

Authors:  J P Miletich; D W Majerus; P W Majerus
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  7 in total

1.  PAR-1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium.

Authors:  Fredda S London; Mariola Marcinkiewicz; Peter N Walsh
Journal:  Biochemistry       Date:  2006-06-13       Impact factor: 3.162

2.  The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation.

Authors:  S S Ahmad; R Rawala; W F Cheung; D W Stafford; P N Walsh
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

3.  Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids.

Authors:  J G Stout; F Bassé; R A Luhm; H J Weiss; T Wiedmer; P J Sims
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding.

Authors:  C R Benedict; R Pakala; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

5.  Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.

Authors:  C R Benedict; J Ryan; B Wolitzky; R Ramos; M Gerlach; P Tijburg; D Stern
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome.

Authors:  H Kojima; D Newton-Nash; H J Weiss; J Zhao; P J Sims; T Wiedmer
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

Review 7.  Interplay between platelets and coagulation.

Authors:  Yaqiu Sang; Mark Roest; Bas de Laat; Philip G de Groot; Dana Huskens
Journal:  Blood Rev       Date:  2020-07-12       Impact factor: 10.626

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.